Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Laryngoscope ; 108(3): 305-10, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9504599

ABSTRACT

OBJECTIVE: Evaluate melatonin as a treatment for subjective tinnitus. STUDY DESIGN: Randomized, prospective, double-blind, placebo-controlled crossover trial. Patients were given 3.0 mg melatonin, which was taken nightly for 30 days followed or preceded by a placebo nightly for 30 days, with a 7-day washout period between medications. SETTING: Outpatient, private, neurotology practice. PATIENTS: Thirty patients with subjective tinnitus. MAIN OUTCOME MEASURES: Tinnitus matching, Tinnitus Handicap Inventory (THI), patient questionnaire and interview. RESULTS: The average pretreatment THI score was 33.91 as compared with 26.43 after the placebo and 26.09 after melatonin. The difference in the THI scores between melatonin and placebo treatment were not statistically significant. The average pretreatment THI score for patients who reported overall improvement with melatonin was statistically higher (P = 0.02) than the average pretreatment THI score for patients who reported no improvement with melatonin. Among subjects reporting difficulty sleeping attributable to their tinnitus, 46.7% reported an overall improvement after melatonin compared with 20.0% for placebo (P = 0.04). There was also a statistically significant difference in improvement with melatonin for those patients with bilateral tinnitus compared with those with unilateral tinnitus (P = 0.02). CONCLUSION: Melatonin has been shown to be useful in the treatment of subjective tinnitus. Patients with high THI scores and/or difficulty sleeping are most likely to benefit from treatment with melatonin. In light of its minimal side effects, melatonin should be a part of the physician's armamentarium in the treatment of tinnitus.


Subject(s)
Melatonin/therapeutic use , Tinnitus/drug therapy , Adult , Aged , Aged, 80 and over , Cross-Over Studies , Double-Blind Method , Female , Humans , Male , Middle Aged , Prospective Studies , Severity of Illness Index , Sleep Wake Disorders/etiology , Tinnitus/classification , Tinnitus/complications , Treatment Outcome
2.
Am J Otol ; 19(2): 196-201, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9520056

ABSTRACT

OBJECTIVE: To investigate the benefits of intratympanic administration of dexamethasone in the treatment of unilateral Meniere's disease, with particular attention to the symptoms of hearing loss and tinnitus. STUDY DESIGN: A prospective, randomized, double-blind, crossover study comparing improvements in hearing loss, tinnitus, aural fullness, and caloric vestibular response secondary to intratympanic dexamethasone and sodium hyaluronate injection versus placebo consisting of saline and sodium hyaluronate. SETTING: A private otology/neurotology practice. PATIENTS: Twenty patients diagnosed with either definite or probable Meniere's disease as defined by the American Academy of Otolaryngology Head and Neck Surgery Committee on Hearing and Equilibrium. All patients were < or =21 years old and were not receiving any other form of treatment for their Meniere's disease. Each patient's primary symptoms of concern were hearing loss, aural fullness, and roaring tinnitus. INTERVENTIONS: Three consecutive daily administrations of intratympanic dexamethasone or placebo to the involved ear. MAIN OUTCOME MEASURES: Changes in audiometric pure-tone averages, speech reception thresholds, caloric vestibular responses, scores on the tinnitus handicap inventories, questionnaires, and telephone interview responses. RESULTS: No significant changes were observed in any measured parameter. Patients were unable to consistently identify which medication was dexamethasone and which was placebo. CONCLUSIONS: Intratympanic administration of dexamethasone in a group of patients with unilateral Meniere's disease (Shea's stage IV) showed no benefit over placebo for the treatment of hearing loss and tinnitus.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Dexamethasone/pharmacology , Dexamethasone/therapeutic use , Ear, Inner/drug effects , Meniere Disease/drug therapy , Adult , Audiometry, Pure-Tone , Cross-Over Studies , Double-Blind Method , Drug Administration Routes , Ear, Inner/pathology , Electronystagmography , Humans , Meniere Disease/pathology , Prospective Studies , Speech Discrimination Tests , Surveys and Questionnaires , Tinnitus/diagnosis , Vestibular Function Tests , Vestibule, Labyrinth/innervation
3.
Am J Otol ; 18(5): 540-3, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9303148

ABSTRACT

OBJECTIVE: This study aimed to evaluate the hearing results obtained using the Silverstein Incus-Stapes Connection in ossicular reconstruction among patients with chronic ear disease. STUDY DESIGN: The study was performed as a retrospective review. A control group consisted of patients undergoing similar surgery but in which no prosthesis was used. SETTING: The Florida Ear and Sinus Center outpatient offices of the senior author. PATIENTS: Forty-seven patients with a mean age of 48 years comprised the treatment group. Thirty-eight patients (mean age, 49.4 years) acted as control subjects. INTERVENTION: All patients underwent surgery for chronic ear disease. Reconstruction surgery for patients requiring separation of the incudostapedial was performed with a Silverstein Incus-Stapes Connection or by reapproximating the joint capsule to allow primary healing. MAIN OUTCOME MEASURE: The patients were categorized according to how the prosthesis was used. Results comparing the preoperative air-bone gap and postoperative air-bone gap were evaluated. The change in air-bone gap was reported according to the guidelines set forth by the Committee on Hearing and Equilibrium. RESULTS: The mean postoperative air-bone gap for reconstruction with the prosthesis was 17.6 dB compared to a mean of 11.8 dB among control subjects. An air-bone gap of 16.5 dB was achieved when the prosthesis was used to bridge an area of lenticular resorption. When a composite prosthesis, made by adding cartilage to the disk, was used to bridge larger defects, an air-bone gap of 14.3 dB was seen. Finally, when the prosthesis was used as a partial ossicular replacement prosthesis and directly contacted the tympanic membrane, the air-bone gap was 9 dB. The prosthesis was found to be stable when re-exploration was required and modification of the prosthesis with cartilage was accomplished easily intraoperatively. CONCLUSION: The Silverstein Incus-Stapes Connection is a middle ear prosthesis that can provide a mechanism for overcoming incus resorption in selected cases. In addition, the prosthesis can be modified easily with the addition of cartilage when needed.


Subject(s)
Incus/surgery , Ossicular Prosthesis , Stapes Surgery , Adolescent , Adult , Aged , Audiometry , Child , Child, Preschool , Equipment Design , Follow-Up Studies , Hearing Disorders/diagnosis , Hearing Disorders/etiology , Humans , Middle Aged , Otitis Media/complications , Retrospective Studies
4.
Am J Otol ; 18(5): 586-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9303154

ABSTRACT

OBJECTIVE: The goal of this investigation was to evaluate the degree of round window membrane obstruction in the native state. The implications for the perfusion of the inner ear via the intratympanic instillation of medications are addressed. STUDY DESIGN: This was a retrospective chart review and a prospective intraoperative observation in the setting of an outpatient office. PATIENTS: The study population was composed of 41 patients who were undergoing middle ear endoscopy before perfusion of the inner ear with medication for the treatment of Meniere's disease, sudden sensorineural hearing loss, or tinnitus. INTERVENTION: Office-based laser-assisted tympanostomy and middle ear endoscopy was carried out in each case. Lysis of adhesions overlying the round window membrane was undertaken when the underlying round window membrane could not be visualized. MAIN OUTCOME MEASURES: Evaluation of the round window niche with regard to accessibility of the round window membrane was recorded for each patient studied. RESULTS: Of the 41 cases examined, 29 of the round windows were judged to be unobstructed, 7 were obstructed partially, and 5 were obstructed completely. CONCLUSION: A significant rate of round window obstruction exists among patients who have no history of manipulation to this area. Although, intuitively, we would expect prior middle ear surgery to increase the likelihood of obstruction, this is not uniformly the outcome. If intratympanic instillation of a medication is contemplated for the treatment of an inner ear disorder, considerations for the evaluation of the round window should be made to enhance adequate diffusion into the perilymph.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chemotherapy, Cancer, Regional Perfusion , Gentamicins/pharmacology , Round Window, Ear/drug effects , Aged , Endoscopy , Female , Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sensorineural/pathology , Hearing Loss, Sensorineural/surgery , Humans , Male , Meniere Disease/drug therapy , Meniere Disease/pathology , Meniere Disease/surgery , Middle Aged , Middle Ear Ventilation , Prospective Studies , Retrospective Studies , Round Window, Ear/pathology , Round Window, Ear/surgery , Tinnitus/drug therapy , Tinnitus/pathology , Tinnitus/surgery
5.
Am J Otol ; 18(4): 507-11, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9233494

ABSTRACT

OBJECTIVE: This study aimed to evaluate the patterns of facial nerve monitoring among graduates of an otology fellowship in which monitoring is emphasized throughout training. STUDY DESIGN: This study involved a questionnaire administered to graduates of the Ear Research Foundation, Sarasota, Florida, U.S.A. (otology/neurotology fellowship). SETTING: The study was performed in academic and private practices of surveyed physicians. MAIN OUTCOME MEASURES: These included patterns of facial nerve monitor use and surgical results after facial nerve injuries. RESULTS: Nearly 100% of the graduates of the Ear Research Foundation continue to use facial nerve monitoring routinely in otologic surgery. Five cases of facial nerve injury in surgery for long-term disease were reported for all 15 neurotologists surveyed. CONCLUSION: Routine facial nerve monitoring is not considered the standard of care in most communities; however risk of facial nerve injury appears to be greatly reduced when this adjunctive technique is employed.


Subject(s)
Education, Medical, Graduate , Facial Nerve/surgery , Adult , Aged , Child , Facial Paralysis/surgery , Female , Humans , Male , Middle Aged , Monitoring, Intraoperative , Surveys and Questionnaires
6.
Ann Otol Rhinol Laryngol ; 106(2): 145-50, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9041820

ABSTRACT

The local metabolic rate of glucose utilization (LMRglc) for the rat vestibular end organs was determined with a modification of the [14C]deoxyglucose method. Data are expressed as micromoles per 100 g per minute +/- SEM. Results indicate that the LMRglc is similar within the utricle (40.3 +/- 3.2) and saccule (41.2 +/- 5.5) and significantly higher than that for the superior (20.1 +/- 2.9), posterior (25.4 +/- 2.0), or lateral canal (22.0 +/- 2.6) ampullae. These differences in LMRglc may be related to differences in the ratios of sensory to nonsensory cells, dark cell distributions, response to acoustic stimulation, or activity levels during the experimental period. Given the high blood flow rates reported for the vestibular end organs by Lyon and coworkers, a much higher LMRglc was expected. Together, these data would suggest that delivery of metabolites is not a primary regulating force for vestibular blood flow. Instead, the primary reason for a high blood flow rate may be waste removal, the maintenance of pH, ion balance, and/or temperature.


Subject(s)
Deoxyglucose/metabolism , Vestibule, Labyrinth/metabolism , Animals , Ear, Inner/metabolism , Male , Rats , Saccule and Utricle/metabolism
8.
Am J Otol ; 16(3): 326-30, 1995 May.
Article in English | MEDLINE | ID: mdl-8588627

ABSTRACT

Glossopharyngeal neuralgia is a rare and often controversial cause for odynophagia and otalgia. The otolaryngologist, head and neck surgeon may be the primary physician called upon to diagnose and treat this entity. In this study, vascular decompression, or more specifically, elimination of contact between the ninth cranial nerve and the posterior inferior cerebellar artery, was employed as treatment in three patients. All achieved relief of their symptoms with this intervention. A review of the neurosurgical literature and the experience with vascular decompression in trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia is presented. The authors conclude that vascular decompression is effective in carefully selected patients, and the role of the skull base surgeon in managing this problem is expanding.


Subject(s)
Cranial Nerve Diseases/diagnosis , Cranial Nerve Diseases/surgery , Glossopharyngeal Nerve , Adult , Aged , Cranial Nerve Diseases/physiopathology , Craniotomy/methods , Facial Neuralgia/diagnosis , Facial Neuralgia/physiopathology , Facial Neuralgia/surgery , Female , Glossopharyngeal Nerve/physiopathology , Glossopharyngeal Nerve/surgery , Humans , Male , Middle Aged , Prognosis , Trigeminal Neuralgia/diagnosis , Trigeminal Neuralgia/physiopathology , Trigeminal Neuralgia/surgery , Vascular Surgical Procedures/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...